Cambridge Healthtech Institute’s Fourth Annual
Companion Diagnostics
Part of the Fourth Annual Next Generation Dx Summit
August 22-23 

More and more drugs as well as therapeutic areas are becoming subjects for companion diagnostic test development. Recent FDA approvals of melanoma drug Zelboraf along with BRAF mutation test, and lung cancer drug Xalkori along with ALK gene test have boosted both enthusiasm and investment in drug-diagnostic co-development. The fourth annual Companion Diagnostics conference will present the point of view of all the stakeholders involved in the process of companion diagnostic test design, manufacturing and clinical implementation. Case studies of successful collaboration between pharmaceutical and diagnostics companies’ researchers will be presented.

Topics may include: 

  • Pharmacogenomics as the driving force for companion diagnostics
  • Tissue-based companion diagnostics
  • From biomarkers in clinical trials to companion diagnostics
  • Solutions and case studies for successful pharma–diagnostics collaboration
  • Various business models for pharma–diagnostics collaboration
  • Regulatory and reimbursement issues
  • Clinical use and utility
  • Acceptance and adoption by practicing physicians

Scientists who wish to present their knowledge and expertise to their colleagues are asked click here to submit an abstract.  Remember to specify the conference that you are interested in and please provide your full contact information.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. 

If you are interested in presenting, please submit a speaking proposal for review. 
Deadline for submission is February 17, 2012 

We welcome your comments, suggestions and speaker referrals as we shape the 2012 program.

For more details on the conference, please contact:
Marina Filshtinsky
Conference Producer
Cambridge Healthtech Institute
Phone: 781-972-5496
Email: mfilshtinsky@healthtech.com 

For exhibit & sponsorship opportunities, please contact:
Joe Vacca
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5431
E: jvacca@healthtech.com